CSPC Innovation Pharmaceutical Co., Ltd.
300765
Rank in Stocks
#2324
Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical... Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company functions as a subsidiary of the larger entity, CSPC Pharmaceutical Group Limited.
Share Price
$6.59
Market Cap
$8.36B
Change (1 day)
-5.40%
Change (1 year)
14.66%
Country
CN
Trade CSPC Innovation Pharmaceutical Co., Ltd. (300765)
Category
Consumer Defensive
Revenue for CSPC Innovation Pharmaceutical Co., Ltd. (300765)
Revenue in Jun 2026 TTM: $651.14M
According to CSPC Innovation Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is $651.14M. In 2024 the company made a revenue of $271.37M a decrease compared to the revenue in the year 2023 that was $358.65M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CSPC Innovation Pharmaceutical Co., Ltd. from 2014 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $651.14M | 112.15% |
| 2025 | $306.92M | 13.10% |
| 2024 | $271.37M | -24.34% |
| 2023 | $358.65M | 23.24% |
| 2022 | $291.02M | 44.31% |
| 2020 | $201.66M | 11.76% |
| 2019 | $180.45M | 0.09% |
| 2018 | $180.28M | 13.75% |
| 2017 | $158.49M | 23.57% |
| 2016 | $128.26M | 12.25% |
| 2015 | $114.27M | 8.77% |
| 2014 | $105.06M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $115.21B | 17,593.31% |
CH
|
|
| $30.86B | 4,639.77% |
FR
|
|
| $10.33B | 1,486.44% |
JP
|
|
| - | - |
BR
|
|
| $24.90B | 3,724.05% |
US
|
